4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzaldehyde

Ref. 3D-FM25654

Informations sur le produit

• Nom: 4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzaldehyde
• Synonymes: 4-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]benzaldehyde
• Marque: Biosynth
• Description: 4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzaldehyde is a hypolipemic agent that acts as an agonist at the peroxisome proliferator-activated receptor α (PPARα). It has been shown to be effective in lowering blood glucose levels in animal models of type 2 diabetes. This compound binds to PPARα, which is expressed in the liver and adipose tissue. 4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzaldehyde has been shown to have hypoglycemic effects by increasing the expression of genes that are involved in lipid metabolism and glucose uptake.; The mechanism of action for this compound is not completely understood but it may be related to its formyl group, which could act as a substrate for cyclization reactions.

Propriétés chimiques

• Masse moléculaire: 307.34 g/mol
• Formule: C₁₉H₁₇NO₃
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C19H17NO3/c1-14-18(20-19(23-14)16-5-3-2-4-6-16)11-12-22-17-9-7-15(13-21)8-10-17/h2-10,13H,11-12H2,1H3
• Code InChI: InChIKey=IPWZPTYWJHXUHD-UHFFFAOYSA-N
• SMILES: Cc1oc(-c2ccccc2)nc1CCOc1ccc(C=O)cc1